The cell penetrating ability of the proapoptotic peptide, KLAKLAKKLAKLAK fused to the N-terminal protein transduction domain of translationally controlled tumor protein, MIIYRDLISH

被引:58
|
作者
Kim, Hyo Young [1 ]
Kim, Seunghoo [2 ,3 ]
Youn, Hyewon [2 ,4 ]
Chung, June-Key [2 ,3 ,4 ]
Shin, Dong Hae [1 ]
Lee, Kyunglim [1 ]
机构
[1] Ewha Womans Univ, Coll Pharm, Ctr Cell Signaling & Drug Discovery Res, Seoul, South Korea
[2] Seoul Natl Univ, Dept Nucl Med, Coll Med, Seoul, South Korea
[3] Seoul Natl Univ, Canc Res Inst, Lab Mol Imaging & Therapy, Seoul, South Korea
[4] Seoul Natl Univ, Med Res Ctr, Inst Radiat Med, Seoul, South Korea
关键词
Apoptosis; Cancer; Molecular imaging; Protein transduction domain; TCTP; TAT PROTEIN; APOPTOSIS; MOLECULES; MECHANISM; DELIVERY;
D O I
10.1016/j.biomaterials.2011.03.074
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We show here, that the proapoptotic peptide, KLAKLAKKLAKLAK (KLA), which by itself does not penetrate cell membranes, can do so when fused to a protein transduction domain derived from NH2-terminus of translationally controlled tumor protein (TCTP-PTD, MIIYRDLISH). Once inside the cell, the conjugated KLA exerts its proapoptotic activity to inhibit tumor growth. We evaluated the cellular uptake of KLA fused to TCTP-PTD (hereafter called TCTP-KLA) and its effect on cancer cell viability. The IC50 of TCTP-KLA was between 7 and 10 mu mol/L. We also evaluated its anti-tumor activity in vivo by injecting it into xenografts of lung carcinoma in Balb/c nude mice. Tumor growth inhibition resulting from treatment with TCTP-KLA was better than that of TAT-KLA. These results suggest that TCTP-KLA can be applied to design cancer therapeutics. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5262 / 5268
页数:7
相关论文
共 50 条
  • [1] Transduction of translationally controlled tumor protein employing TCTP-derived protein transduction domain
    Maeng, Jeehye
    Kim, Hyo Young
    Shin, Dong Hae
    Lee, Kyunglim
    ANALYTICAL BIOCHEMISTRY, 2013, 435 (01) : 47 - 53
  • [2] An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity
    Yu Yang
    Fan Yang
    Zeyu Xiong
    Yan Yan
    Xinmen Wang
    Michiya Nishino
    Dragan Mirkovic
    Justin Nguyen
    Hong Wang
    Xiao-Feng Yang
    Oncogene, 2005, 24 : 4778 - 4788
  • [3] An N-terminal region of translationally controlled tumor protein is required for its antiapoptotic activity
    Yang, Y
    Yang, F
    Xiong, ZY
    Yan, Y
    Wang, XM
    Nishino, M
    Mirkovic, D
    Nguyen, J
    Wang, H
    Yang, XF
    ONCOGENE, 2005, 24 (30) : 4778 - 4788
  • [4] Protein transduction domain of translationally controlled tumor protein: characterization and application in drug delivery
    Maeng, Jeehye
    Lee, Kyunglim
    DRUG DELIVERY, 2022, 29 (01) : 3009 - 3021
  • [5] Design and evaluation of variants of the protein transduction domain originated from translationally controlled tumor protein
    Kim, Moonhee
    Maeng, Jeehye
    Jung, Jaehoon
    Kim, Hyo Young
    Kim, Hwa-Jung
    Kwon, Youngjoo
    Lee, Kyunglim
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 43 (1-2) : 25 - 31
  • [6] On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs
    Bae, Hae-duck
    Lee, Kyunglim
    JOURNAL OF CONTROLLED RELEASE, 2013, 170 (03) : 358 - 364
  • [7] Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin
    Bae, Hae-Duck
    Lee, Joohyun
    Jun, Kyu-Yeon
    Kwon, Youngjoo
    Lee, Kyunglim
    DRUG DELIVERY, 2018, 25 (01) : 1025 - 1032
  • [8] Binding of Translationally Controlled Tumour Protein to the N-Terminal Domain of HDM2 Is Inhibited by Nutlin-3
    Funston, Garth
    Goh, Walter
    Wei, Siau Jia
    Tng, Quah Soo
    Brown, Christopher
    Tong, Loh Jiah
    Verma, Chandra
    Lane, David
    Ghadessy, Farid
    PLOS ONE, 2012, 7 (08):
  • [9] Modified Translationally Controlled Tumor Protein-Derived Protein Transduction Domain Enhances Nasal Delivery of Peptides.
    Kim, Moonhee
    Bae, Hae-duck
    Lee, Joohyun
    Lee, Kyunglim
    PROTEIN SCIENCE, 2018, 27 : 201 - 201
  • [10] Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain
    Bae, Hae-Duck
    Lee, Ji-Sun
    Pyun, Haejun
    Kim, Moonhee
    Lee, Kyunglim
    DRUG DELIVERY, 2019, 26 (01) : 622 - 628